TWO-YEAR ADMINISTRATION DATA OF AN ORAL TESTOSTERONE UNDECANOATE (TU) FORMULATION IN HYPOGONADAL MEN

被引：0
|
作者：
Swerdloff, R. [1 ]
Honig, S. [2 ]
Wang, C. [1 ]
Gittelman, M. [3 ]
Sea, B. W. [4 ]
Rohowsky, N. [5 ]
Dudley, R. [1 ]
机构：
[1] Lundquist Inst Harbor UCLA, Los Angeles, CA USA
[2] Yale Sch Med, New Haven, CT USA
[3] UroMedix & South Florida Med Res, Aventura, FL USA
[4] Clarus Therapeut, Northbrook, IL USA
[5] Integrated Data Consultat Serv Inc, Bellrosemanor, NY USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2022年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MALE PATIENTS
    FRANCHIMONT, P
    KICOVIC, PM
    MATTEI, A
    ROULIER, R
    CLINICAL ENDOCRINOLOGY, 1978, 9 (04) : 313 - 320
  • [22] HYPOGONADAL MEN TREATED WITH AN ORAL TESTOSTERONE UNDECANOATE HAD PERSISTENT IMPROVED SEXUAL SYMPTOM SCORES OVER ONE YEAR
    Wang, C.
    Swerdloff, R.
    Gittelman, M.
    Seo, B. W.
    Rohowsky, N.
    Dudley, R.
    JOURNAL OF SEXUAL MEDICINE, 2021, 18 (03): : S15 - S16
  • [23] A new oral testosterone undecanoate formulation
    Köhn, FM
    Schill, WB
    WORLD JOURNAL OF UROLOGY, 2003, 21 (05) : 311 - 315
  • [24] A new oral testosterone undecanoate formulation
    Frank-Michael Köhn
    Wolf-Bernhard Schill
    World Journal of Urology, 2003, 21 : 311 - 315
  • [25] LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU) IN HYPOGONADAL MEN WITH CARDIOVASCULAR DISEASES (CVD): OBSERVATIONAL DATA FROM A REGISTRY STUDY
    Haider, Ahmad
    Haider, Karim Sultan
    Doros, Gheorghe
    Traish, Abdulmaged
    JOURNAL OF UROLOGY, 2015, 193 (04): : E771 - E771
  • [26] ERECTILE FUNCTION IN 656 HYPOGONADAL MEN WITH AND WITHOUT LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU)
    Saad, F.
    Doros, G.
    Haider, A.
    Haider, K.
    Traish, A.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S114 - S114
  • [27] Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome
    Antonio Aversa
    R. Bruzziches
    D. Francomano
    G. Spera
    A. Lenzi
    Journal of Endocrinological Investigation, 2010, 33 : 776 - 783
  • [28] Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome
    Aversa, A.
    Bruzziches, R.
    Francomano, D.
    Spera, G.
    Lenzi, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2010, 33 (11) : 776 - 783
  • [29] ORAL TESTOSTERONE UNDECANOATE (316 MG BID) QUICKLY AND EFFECTIVELY INCREASES SERUM TESTOSTERONE CONCENTRATIONS IN HYPOGONADAL MEN
    Khera, Mohit
    Boldt-Houle, Deborah M.
    Daugherty, Rhea
    Atkinson, Stuart N.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1073 - E1073
  • [30] Comparison of analytical approaches for the detection of oral testosterone undecanoate administration in men
    Langer, Tobias
    Nicoli, Raul
    Schweizer-Grundisch, Carine
    Grabherr, Silke
    Kuuranne, Tiia
    Musenga, Alessandro
    DRUG TESTING AND ANALYSIS, 2024, 16 (10) : 1155 - 1166
12345